Adipokines in liver diseases (Q37544637)

20 August 2017

1 reference

title

Adipokines in liver diseases (English)

1 reference

20 August 2017

Fabio Marra

1

1 reference

20 August 2017

Cristiana Bertolani

series ordinal

2

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 September 2009

1 reference

20 August 2017

1 reference

20 August 2017

volume

50

1 reference

20 August 2017

issue

3

1 reference

20 August 2017

page(s)

957-969

1 reference

Obesity-associated liver disease

20 August 2017

cites work

1 reference

7 January 2021

Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity

1 reference

7 January 2021

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

1 reference

7 January 2021

Abdominal obesity and metabolic syndrome

1 reference

7 January 2021

Mechanisms of leptin action and leptin resistance

1 reference

7 January 2021

Liver adenosine monophosphate-activated kinase-alpha2 catalytic subunit is a key target for the control of hepatic glucose production by adiponectin and leptin but not insulin

1 reference

7 January 2021

Adipokines and insulin resistance

1 reference

7 January 2021

Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy

1 reference

7 January 2021

Impairment of hepatic Stat-3 activation and reduction of PPARalpha activity in fructose-fed rats

1 reference

7 January 2021

Suppressor of cytokine signaling-3 (SOCS-3) and a deficit of serine/threonine (Ser/Thr) phosphoproteins involved in leptin transduction mediate the effect of fructose on rat liver lipid metabolism

1 reference

7 January 2021

Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice

1 reference

7 January 2021

High circulating leptin receptors with normal leptin sensitivity in liver-specific insulin receptor knock-out (LIRKO) mice

1 reference

7 January 2021

Hepatic leptin signaling in obesity.

1 reference

7 January 2021

Leptin-deficient (ob/ob) mice are protected from T cell-mediated hepatotoxicity: role of tumor necrosis factor alpha and IL-18.

1 reference

7 January 2021

Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis

1 reference

7 January 2021

Leptin deficiency enhances sensitivity of rats to alcoholic steatohepatitis through suppression of metallothionein

1 reference

7 January 2021

Leptin downregulates ethanol-induced secretion of proinflammatory cytokines and growth factor

1 reference

7 January 2021

Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat.

1 reference

7 January 2021

Leptin is essential for the hepatic fibrogenic response to chronic liver injury

1 reference

7 January 2021

Leptin and liver tissue repair: do rodent models provide the answers?

1 reference

7 January 2021

Role of endogenous opioids in modulating HSC activity in vitro and liver fibrosis in vivo

1 reference

7 January 2021

Leptin induces phagocytosis of apoptotic bodies by hepatic stellate cells via a Rho guanosine triphosphatase-dependent mechanism

1 reference

7 January 2021

The roles of leptin and adiponectin: a novel paradigm in adipocytokine regulation of liver fibrosis and stellate cell biology

1 reference

7 January 2021

Leptin-specific mechanisms for impaired liver regeneration in ob/ob mice after toxic injury

1 reference

7 January 2021

Limited therapeutic efficacy of pioglitazone on progression of hepatic fibrosis in rats

1 reference

7 January 2021

Biological action of leptin as an angiogenic factor

1 reference

7 January 2021

Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells.

1 reference

7 January 2021

Leptin-mediated neovascularization is a prerequisite for progression of nonalcoholic steatohepatitis in rats.

1 reference

7 January 2021

Leptin-leptin receptor are involved in angiogenesis in human hepatocellular carcinoma

1 reference

7 January 2021

Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells

1 reference

7 January 2021

Leptin enhances cholangiocarcinoma cell growth

1 reference

7 January 2021

Leptin's mitogenic effect in human liver cancer cells requires induction of both methionine adenosyltransferase 2A and 2beta

1 reference

7 January 2021

Adoptive transfer of regulatory NKT lymphocytes ameliorates non-alcoholic steatohepatitis and glucose intolerance in ob/ob mice and is associated with intrahepatic CD8 trapping

1 reference

7 January 2021

Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome

1 reference

7 January 2021

The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice

1 reference

7 January 2021

Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice

1 reference

7 January 2021

Inhibition of adiponectin production by homocysteine: a potential mechanism for alcoholic liver disease

1 reference

7 January 2021

Adiponectin protects LPS-induced liver injury through modulation of TNF-alpha in KK-Ay obese mice

1 reference

7 January 2021

Obesity-associated improvements in metabolic profile through expansion of adipose tissue

1 reference

7 January 2021

1 reference

7 January 2021

Redox-dependent and ligand-independent trans-activation of insulin receptor by globular adiponectin

1 reference

7 January 2021

Adiponectin resistance exacerbates insulin resistance in insulin receptor transgenic/knockout mice

1 reference

7 January 2021

Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity

1 reference

7 January 2021

Fetuin-A induces cytokine expression and suppresses adiponectin production

1 reference

7 January 2021

Adipocytokines: mediators linking adipose tissue, inflammation and immunity

1 reference

7 January 2021

Adiponectin actions in the cardiovascular system

1 reference

7 January 2021

Regulation of T cell-mediated hepatic inflammation by adiponectin and leptin

1 reference

7 January 2021

Adiponectin inhibits steatotic CD95/Fas up-regulation by hepatocytes: therapeutic implications for hepatitis C.

1 reference

7 January 2021

Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis

1 reference

7 January 2021

Activation of peroxisome proliferator-activated receptor-alpha inhibits the injurious effects of adiponectin in rat steatotic liver undergoing ischemia-reperfusion

1 reference

7 January 2021

Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin

1 reference

7 January 2021

Adenosine monophosphate-activated protein kinase modulates the activated phenotype of hepatic stellate cells.

1 reference

7 January 2021

High molecular weight adiponectin inhibits proliferation of hepatic stellate cells via activation of adenosine monophosphate-activated protein kinase

1 reference

7 January 2021

Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice

1 reference

7 January 2021

Hypoadiponectinemia accelerates hepatic tumor formation in a nonalcoholic steatohepatitis mouse model

1 reference

7 January 2021

Delayed liver regeneration after partial hepatectomy in adiponectin knockout mice

1 reference

7 January 2021

The hormone resistin links obesity to diabetes

1 reference

7 January 2021

Hypothalamic resistin induces hepatic insulin resistance

1 reference

7 January 2021

Regulation of fasted blood glucose by resistin

1 reference

7 January 2021

Loss of resistin ameliorates hyperlipidemia and hepatic steatosis in leptin-deficient mice

1 reference

7 January 2021

New role of resistin in lipopolysaccharide-induced liver damage in mice

1 reference

7 January 2021

Stimulated resistin expression in white adipose of rats with bile duct ligation-induced liver cirrhosis: relationship to cirrhotic hyperinsulinemia and increased tumor necrosis factor-alpha

1 reference

7 January 2021

Resistin as an intrahepatic cytokine: overexpression during chronic injury and induction of proinflammatory actions in hepatic stellate cells

1 reference

7 January 2021

Adipogenic transcriptional regulation of hepatic stellate cells

1 reference

7 January 2021

Insulin sensitivity: modulation by nutrients and inflammation

1 reference

7 January 2021

Obesity, Inflammation, and Insulin Resistance

1 reference

7 January 2021

Inflammatory pathways in liver homeostasis and liver injury

1 reference

7 January 2021

Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor

1 reference

7 January 2021

Adiposity dependent apelin gene expression: relationships with oxidative and inflammation markers

1 reference

7 January 2021

The hepatic apelin system: a new therapeutic target for liver disease

1 reference

7 January 2021

Apelin signaling modulates splanchnic angiogenesis and portosystemic collateral vessel formation in rats with portal hypertension.

1 reference

7 January 2021

Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme

1 reference

7 January 2021

Adipokines in obesity

1 reference

7 January 2021

Serum leptin levels in patients with nonalcoholic steatohepatitis

1 reference

7 January 2021

Risk of severe liver disease in NAFLD with normal ALT levels: a pediatric report.

1 reference

7 January 2021

Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity?

1 reference

7 January 2021

Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease

1 reference

7 January 2021

Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

1 reference

7 January 2021

Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease

1 reference

7 January 2021

Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease

1 reference

7 January 2021

Inverse association between serum adiponectin level and transaminase activities in Japanese male workers

1 reference

7 January 2021

Gene expression of leptin, resistin, and adiponectin in the white adipose tissue of obese patients with non-alcoholic fatty liver disease and insulin resistance

1 reference

7 January 2021

Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity

1 reference

7 January 2021

Postprandial lipemia associates with liver fat content.

1 reference

7 January 2021

Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular risk

1 reference

7 January 2021

Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients

1 reference

7 January 2021

Adiponectin and its receptors in non-alcoholic steatohepatitis.

1 reference

7 January 2021

Is adiponectin involved in the pathogenesis of nonalcoholic steatohepatitis? A preliminary human study

1 reference

7 January 2021

Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?

1 reference

7 January 2021

The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects

1 reference

7 January 2021

Interaction of fish oil and conjugated linoleic acid in affecting hepatic activity of lipogenic enzymes and gene expression in liver and adipose tissue

1 reference

7 January 2021

Adiponectin genetic variability, plasma adiponectin, and cardiovascular risk in patients with type 2 diabetes

1 reference

7 January 2021

Adiponectin gene polymorphisms modulate acute adiponectin response to dietary fat: Possible pathogenetic role in NASH.

1 reference

7 January 2021

Polymorphisms in the gene encoding adiponectin receptor 1 are associated with insulin resistance and high liver fat.

1 reference

7 January 2021

Plasma adiponectin levels in primary biliary cirrhosis: a novel perspective for link between hypercholesterolemia and protection against atherosclerosis

1 reference

7 January 2021

Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance.

1 reference

7 January 2021

Insulin resistance and whole body energy homeostasis in obese adolescents with fatty liver disease

1 reference

7 January 2021

Adipokines and cytokines in non-alcoholic fatty liver disease

1 reference

7 January 2021

High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans

1 reference

7 January 2021

Serum retinol-binding protein-4, leptin, and adiponectin concentrations are related to ectopic fat accumulation

1 reference

7 January 2021

Serum retinol binding protein 4 and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus

1 reference

7 January 2021

Hepatitis C infection and nonalcoholic fatty liver disease

1 reference

7 January 2021

Hepatitis C virus infection: molecular pathways to metabolic syndrome

1 reference

7 January 2021

Alterations of leptin during IFN-alpha therapy in patients with chronic viral hepatitis

1 reference

7 January 2021

Leptin has no role in determining severity of steatosis and fibrosis in patients with chronic hepatitis C.

1 reference

7 January 2021

Serum leptin levels in patients with viral chronic hepatitis or liver cirrhosis

1 reference

7 January 2021

Plasma leptin and TNF-alpha levels in chronic hepatitis C patients and their relationship to hepatic fibrosis

1 reference

7 January 2021

The severity of liver fibrosis is associated with high leptin levels in chronic hepatitis C

1 reference

7 January 2021

Hepatic steatosis in chronic hepatitis B and C: predictors, distribution and effect on fibrosis

1 reference

7 January 2021

Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C.

1 reference

7 January 2021

Adiponectin levels among patients with chronic hepatitis B and C infections and in response to IFN-alpha therapy

1 reference

7 January 2021

Serum adiponectin concentration in patients with hepatitis C virus

1 reference

7 January 2021

Insulin resistance and liver injury in hepatitis C is not associated with virus-specific changes in adipocytokines

1 reference

7 January 2021

Decreased plasma adiponectin concentrations are closely related to steatosis in hepatitis C virus-infected patients

1 reference

7 January 2021

Adiponectin and its receptors in patients with chronic hepatitis C.

1 reference

7 January 2021

Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-? in chronic hepatitis C patients

1 reference

7 January 2021

High molecular weight adiponectin correlates with insulin sensitivity in patients with hepatitis C genotype 3, but not genotype 1 infection.

1 reference

7 January 2021

Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C.

1 reference

7 January 2021

A novel role for adiponectin in regulating the immune responses in chronic hepatitis C virus infection.

1 reference

7 January 2021

Serum adiponectin in chronic hepatitis C and B.

1 reference

7 January 2021

Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity

1 reference

7 January 2021

Serum adiponectin is increased in advancing liver fibrosis and declines with reduction in fibrosis in chronic hepatitis B.

1 reference

7 January 2021

Retinol-binding protein 4: a new marker of virus-induced steatosis in patients infected with hepatitis c virus genotype 1.

1 reference

7 January 2021

Gender-dependent alterations in serum leptin in alcoholic cirrhosis

1 reference

7 January 2021

Serum leptin in patients with alcoholic liver disease

1 reference

7 January 2021

Serum leptin levels in post-hepatitis liver cirrhosis

1 reference

7 January 2021

Elevated bound leptin correlates with energy expenditure in cirrhotics

1 reference

7 January 2021

Distinct roles of free leptin, bound leptin and soluble leptin receptor during the metabolic-inflammatory response in patients with liver cirrhosis

1 reference

7 January 2021

Increased circulating leptin in alcoholic cirrhosis: Relation to release and disposal

1 reference

7 January 2021

Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics

1 reference

7 January 2021

High adiponectin in chronic liver disease and cholestasis suggests biliary route of adiponectin excretion in vivo

1 reference

7 January 2021

Resistin serum levels are associated with insulin resistance, disease severity, clinical complications, and prognosis in patients with chronic liver diseases

1 reference

7 January 2021

Elevated resistin levels in cirrhosis are associated with the proinflammatory state and altered hepatic glucose metabolism but not with insulin resistance

1 reference

7 January 2021

Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis

1 reference

7 January 2021

Insulin resistance in liver cirrhosis is not associated with circulating retinol-binding protein 4.

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.23046

1 reference

20 August 2017

1 reference